Biblio

Export 335 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is I  [Clear All Filters]
2016
M. Abdullah, Takase, H., Nunome, M., Enomoto, H., Ito, J. - I., Gong, J. - S., and Michikawa, M., Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation., J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
L. Fortunato Araújo, Mirza, S. Saeed, Bos, D., Niessen, W. J., Barreto, S. Maria, van der Lugt, A., Vernooij, M. W., Hofman, A., Tiemeier, H., and M Ikram, A., Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study., J Alzheimers Dis, vol. 53, no. 2, pp. 451-61, 2016.
A. V. Ivachtchenko, Lavrovsky, Y., and Okun, I., AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders., J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
M. Pietto, Parra, M. A., Trujillo, N., Flores, F., García, A. M., Bustin, J., Richly, P., Manes, F., Lopera, F., Ibáñez, A., and Baez, S., Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1325-40, 2016.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab., J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
A. Mishima, Nihashi, T., Ando, Y., Kawai, H., Kato, T., Ito, K., and Terasawa, T., Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis., J Alzheimers Dis, vol. 50, no. 1, pp. 161-74, 2016.
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease., J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
S. Akoudad, M Gurol, E., Fotiadis, P., Koudstaal, P. J., Hofman, A., M Ikram, A., Greenberg, S. M., and Vernooij, M. W., Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study., J Alzheimers Dis, vol. 53, no. 2, pp. 497-503, 2016.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M., Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study., J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study., J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study., J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
J. Ku Chung, Plitman, E., Nakajima, S., M Chakravarty, M., Caravaggio, F., Takeuchi, H., Gerretsen, P., Iwata, Y., Patel, R., Mulsant, B. H., and Graff-Guerrero, A., Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment., J Alzheimers Dis, vol. 49, no. 3, pp. 743-54, 2016.
A. Dodich, Cerami, C., Crespi, C., Canessa, N., Lettieri, G., Iannaccone, S., Marcone, A., Cappa, S. F., and Cacioppo, J. T., Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1011-22, 2016.
T. Hisatsune, Kaneko, J., Kurashige, H., Cao, Y., Satsu, H., Totsuka, M., Katakura, Y., Imabayashi, E., and Matsuda, H., Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People., J Alzheimers Dis, vol. 50, no. 1, pp. 149-59, 2016.
C. Huang, Ng, O. Tsz- Wa, Ho, Y. - S., Irwin, M. Garnet, Chang, R. Chuen- Chun, and Wong, G. Tin- Chun, Effect of Continuous Propofol Infusion in Rat on Tau Phosphorylation with or without Temperature Control., J Alzheimers Dis, vol. 51, no. 1, pp. 213-26, 2016.
K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial., J Alzheimers Dis, vol. 52, no. 4, pp. 1277-98, 2016.
Y. Yoshino, Mori, T., Yoshida, T., Yamazaki, K., Ozaki, Y., Sao, T., Funahashi, Y., Iga, J. - I., and Ueno, S. - I., Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects., J Alzheimers Dis, vol. 54, no. 4, pp. 1349-1357, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
V. Chouraki, Reitz, C., Maury, F., Bis, J. C., Bellenguez, C., Yu, L., Jakobsdottir, J., Mukherjee, S., Adams, H. H., Choi, S. Hoan, Larson, E. B., Fitzpatrick, A., Uitterlinden, A. G., De Jager, P. L., Hofman, A., Gudnason, V., Vardarajan, B., Ibrahim-Verbaas, C., van der Lee, S. J., Lopez, O., Dartigues, J. - F., Berr, C., Amouyel, P., Bennett, D. A., van Duijn, C., DeStefano, A. L., Launer, L. J., M Ikram, A., Crane, P. K., Lambert, J. - C., Mayeux, R., and Seshadri, S., Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.

Pages